We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Bioresorbable Implantable Device Could Treat Pain After Surgery

By HospiMedica International staff writers
Posted on 13 Sep 2022
Print article
Image: A soft, bioresorbable, implantable device blocks pain signals from peripheral nerves (Photo courtesy of Pusan National University)
Image: A soft, bioresorbable, implantable device blocks pain signals from peripheral nerves (Photo courtesy of Pusan National University)

Researchers have developed a soft, bioresorbable, implantable device with the potential to cool peripheral nerves in a minimally invasive, focused manner that could be used to treat pain after surgery.

To develop the device, a team of researchers from Pusan National University (Busan, South Korea) designed a microfluidics system formed with a bioresorbable material - poly(octanediol citrate) - with interconnects carrying a liquid coolant to a serpentine chamber. To top it off, a Magnesium temperature sensor for real-time temperature monitoring was incorporated at its distal end. The intensity and localization of the cooling effect was regulated by perfluoro pentane (PFP) and dry nitrogen gas (N2) - the two components of the liquid coolant, as well as the geometry of the serpentine chamber.

Next, the team tested the device by implanting it into the sciatic nerves of living rat models with neuropathic pain associated with spared nerve injury. After a three-week evaluation, the team found that the device successfully delivered cooling power to the peripheral nerves of the rats, which led to a reduction in their pain. Fortunately, the delivery of the cooling power occurred in a minimally invasive, stable, and precise manner. Moreover, this application was localized and reversible, and remained effective for almost 15 minutes during one session. On being submerged in phosphate-buffered saline solution at 75°C, the device, which was made of bioresorbable materials, dissolved within 20 days and was eliminated in approximately 50 days. These findings imply that it has the potential to naturally degrade and get resorbed in the human body.

“The developed device can be used to treat pain after surgery,” said Professor Min-Ho Seo from Pusan National University who led the team of researchers and believes the device could have important future applications. “Since it is connected to an external source of fluid and power like a commercial intravenous (IV) device, it can easily be controlled by the patient. This way, our implantable device will be able to provide targeted and individualized relief without the drawbacks of the addictive pain medications.”

Related Links:
Pusan National University

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Radial Shock Wave Device
MASTERPULS »ultra«

Print article

Channels

Critical Care

view channel
Image: The potential for controlling diabetes with a single endoscopic treatment is spectacular (Photo courtesy of 123RF)

One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes

Over 37 million Americans are diagnosed with diabetes, and more than 90% of these cases are Type 2 diabetes. This form of diabetes is most commonly seen in individuals over 45, though an increasing number... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more